Diisopropanolamine

Diisopropanolamine

SCHEMBL3362609

CC(O)CNCC(C)O.Cl

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Diisopropanolamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ADRB2 known ✓ P07550 1/20 0.32
ALDH1A1 P00352 5/20 0.43
CYP1A2 P05177 3/20 0.43
CYP2D6 P10635 3/20 0.43
TSHR P16473 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
KMT2A Q03164 1/20 0.39
CYP2C19 P33261 1/20 0.34
LMNA P02545 1/20 0.33
KDM4E B2RXH2 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ANPEP P15144 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diisopropanolamine SCHEMBL22774 0.96
Diisopropanolamine SCHEMBL10618901 0.96
Diisopropanolamine SCHEMBL839563 0.93 TSHR (0.41) ALDH1A1CYP1A2CYP2D6TSHRTDP1
Diisopropanolamine SCHEMBL28590399 0.93 TSHR (0.41) ALDH1A1CYP1A2CYP2D6TSHRTDP1
Diisopropanolamine SCHEMBL6858463 0.93 TSHR (0.41) ALDH1A1CYP1A2CYP2D6TSHRTDP1
Diisopropanolamine SCHEMBL26967085 0.93 TSHR (0.41) ALDH1A1CYP1A2CYP2D6TSHRTDP1
Diisopropanolamine SCHEMBL28181731 0.93 TSHR (0.41) ALDH1A1CYP1A2CYP2D6TSHRTDP1
Diisopropanolamine SCHEMBL7592152 0.93 TSHR (0.41) ALDH1A1CYP1A2CYP2D6TSHRTDP1
Diisopropanolamine SCHEMBL28262309 0.90 TSHR (0.39) ALDH1A1CYP1A2CYP2D6TSHRTDP1
SCHEMBL23665148 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3148270-A None JP disclosed
JP-3130261-A None JP disclosed
CN-217988434-U Dryer for separating high-salt 2, 6-dimethyl morpholine 江苏富比亚化学品有限公司 2022-12-09 CN disclosed
EP-3011954-A1 EXTERNAL PREPARATION COMPOSITION COMPRISING FATTY ACID-BASED IONIC LIQUID AS ACTIVE INGREDIENT Medrx Co., Ltd. (JP) 2016-04-27 EP disclosed
US-20140066471-A1 EXTERNAL PREPARATION COMPOSITION COMPRISING FATTY ACID-BASED IONIC LIQUID AS ACTIVE INGREDIENT MEDRX CO., LTD. (JP) 2014-03-06 US disclosed
US-8623387-B2 External preparation composition comprising fatty acid-based ionic liquid as active ingredient MEDRX CO., LTD. (JP) 2014-01-07 US disclosed
US-20100256174-A1 EXTERNAL PREPARATION COMPOSITION COMPRISING FATTY ACID-BASED IONIC LIQUID AS ACTIVE INGREDIENT MEDRX CO., LTD. (JP) 2010-10-07 US disclosed
EP-2223703-A1 EXTERNAL PREPARATION COMPOSITION COMPRISING FATTY ACID-BASED IONIC LIQUID AS ACTIVE INGREDIENT Medrx Co., Ltd. (JP) 2010-09-01 EP disclosed
US-5925893-A POLYESTERURETHANE IONOMER FUJI XEROX CO., LTD. (JP) 1999-07-20 US disclosed
JP-H03148270-A THREE-LIQUID-PHASE EPOXYLATION OF PERFLUOROOLEFINE E I DU PONT DE NEMOURS & CO 1991-06-25 JP disclosed
JP-H03130261-A 1-PHENYL-SUBSTITUTED-5-EXO-METHYLENE-PYRROLIDIN-2-ONE AND 2-PHENYL-SUBSTITUTED-3-EXO-METHYLENE-4,5,6,7-TETRAHYDROISOINDOL-(2H)-1-ONE HAVING HERBICIDAL ACTIVITY CIBA GEIGY AG 1991-06-04 JP disclosed
EP-0142742-B1 PROCESS FOR REMOVING WATER FROM 2,6-DIMETHYL MORPHOLINE HÜLS AKTIENGESELLSCHAFT (DE) 1988-11-30 EP disclosed